{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:47:10Z","timestamp":1791100030121,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T00:00:00Z","timestamp":1329523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s12185-012-1022-0","type":"journal-article","created":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T16:31:33Z","timestamp":1329496293000},"page":"285-290","source":"Crossref","is-referenced-by-count":8,"title":["Frequency of inherited variants in the MEFV gene in myelodysplastic syndrome and acute myeloid leukemia"],"prefix":"10.1007","volume":"95","author":[{"given":"Serkan","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"Oktenli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Kilicaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Tangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Sayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Onur","family":"Ozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Ipcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz S.","family":"Sanisoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hakan","family":"Terekeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev A.","family":"Erikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,18]]},"reference":[{"key":"1022_CR1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00296-008-0648-y","volume":"28","author":"HM Terekeci","year":"2008","unstructured":"Terekeci HM, Ulusoy ER, Kucukarslan NM, Nalbant S, Oktenli C. Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters. Rheumatol Int. 2008;28:1239\u201343.","journal-title":"Rheumatol Int"},{"key":"1022_CR2","first-page":"2024","volume":"35","author":"HM Terekeci","year":"2008","unstructured":"Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, et al. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol. 2008;35:2024\u20139.","journal-title":"J Rheumatol"},{"key":"1022_CR3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2249.2004.02632.x","volume":"138","author":"U Musabak","year":"2004","unstructured":"Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, et al. Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol. 2004;138:526\u201333.","journal-title":"Clin Exp Immunol"},{"key":"1022_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","volume":"17","author":"The French FMF Consortium","year":"1997","unstructured":"The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25\u201331.","journal-title":"Nat Genet"},{"key":"1022_CR5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","volume":"90","author":"The International FMF Consortium","year":"1997","unstructured":"The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797\u2013807.","journal-title":"Cell"},{"key":"1022_CR6","unstructured":"Touitou I. Infevers Database. http:\/\/fmf.igh.cnrs.fr\/ISSAID\/infevers\/search.php?n=1 ."},{"key":"1022_CR7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","volume":"9","author":"I Touitou","year":"2001","unstructured":"Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473\u201383.","journal-title":"Eur J Hum Genet"},{"key":"1022_CR8","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","volume":"95","author":"M Centola","year":"2000","unstructured":"Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood. 2000;95:3223\u201331.","journal-title":"Blood"},{"key":"1022_CR9","first-page":"2070","volume":"34","author":"B Koc","year":"2007","unstructured":"Koc B, Oktenli C, Bulucu F, Karadurmus N, Sanisoglu SY, Gul D. The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study. J Rheumatol. 2007;34:2070\u20135.","journal-title":"J Rheumatol"},{"key":"1022_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20032234","volume":"200","author":"C Stehlik","year":"2004","unstructured":"Stehlik C, Reed JC. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med. 2004;200:551\u20138.","journal-title":"J Exp Med"},{"key":"1022_CR11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00056-X","volume":"11","author":"JJ Chae","year":"2003","unstructured":"Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591\u2013604.","journal-title":"Mol Cell"},{"key":"1022_CR12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0006-291X(03)00221-3","volume":"302","author":"TA Dowds","year":"2003","unstructured":"Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin\/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun. 2003;302:575\u201380.","journal-title":"Biochem Biophys Res Commun"},{"key":"1022_CR13","first-page":"S45","volume":"20","author":"DL Gumucio","year":"2002","unstructured":"Gumucio DL, Diaz A, Schaner P, Richards N, Babcock C, Schaller M, et al. Fire and ICE: the role of pyrin domain containing proteins in inflammation and apoptosis. Clin Exp Rheumatol. 2002;20:S45\u201353.","journal-title":"Clin Exp Rheumatol"},{"key":"1022_CR14","doi-asserted-by":"crossref","first-page":"11570","DOI":"10.1074\/jbc.M112208200","volume":"277","author":"GA Manji","year":"2002","unstructured":"Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, Al-Garawi A, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem. 2002;277:11570\u20135.","journal-title":"J Biol Chem"},{"key":"1022_CR15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/bj20030304","volume":"373","author":"C Stehlik","year":"2003","unstructured":"Stehlik C, Krajewska M, Welsh K, Krajewski S, Godzik A, Reed JC. The PAAD\/PYRIN-only protein POP1\/ASC2 is a modulator of ASC-mediated NF-\u03baB and pro-caspase-1 regulation. Biochem J. 2003;373:101\u201313.","journal-title":"Biochem J"},{"key":"1022_CR16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.20021552","volume":"196","author":"C Stehlik","year":"2002","unstructured":"Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J, et al. The PAAD\/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med. 2002;196:1605\u201315.","journal-title":"J Exp Med"},{"key":"1022_CR17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.cdd.4402142","volume":"14","author":"S Papin","year":"2007","unstructured":"Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, et al. The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1\u03b2 processing. Cell Death Differ. 2007;14:1457.","journal-title":"Cell Death Differ"},{"key":"1022_CR18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/bor.0000174210.78449.6b","volume":"17","author":"S Stojanov","year":"2005","unstructured":"Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheum. 2005;17:586.","journal-title":"Curr Opin Rheum"},{"key":"1022_CR19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bcp.2006.06.011","volume":"72","author":"A Keutgens","year":"2006","unstructured":"Keutgens A, Robert I, Viatour P, Chariot A. Deregulated NF-\u03baB activity in haematological malignancies. Biochem Pharmacol. 2006;72:1069\u201380.","journal-title":"Biochem Pharmacol"},{"key":"1022_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/j.seminhematol.2004.02.002","volume":"41","author":"P Fenaux","year":"2004","unstructured":"Fenaux P. Myelodysplastic syndromes: from pathogenesis and prognosis to treatment. Semin Hematol. 2004;41:6\u201312.","journal-title":"Semin Hematol"},{"key":"1022_CR21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2005-05-1989","volume":"107","author":"T Braun","year":"2006","unstructured":"Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F, et al. NF-\u03baB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006;107:1156\u201365.","journal-title":"Blood"},{"key":"1022_CR22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1365-2141.2000.02472.x","volume":"111","author":"RA Padua","year":"2000","unstructured":"Padua RA, West RR. Oncogene mutation and prognosis in the myelodysplastic syndromes. Br J Haematol. 2000;111:873\u20134.","journal-title":"Br J Haematol"},{"key":"1022_CR23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.leu.2403274","volume":"18","author":"LY Shih","year":"2004","unstructured":"Shih LY, Huang CF, Wang PN, Wu JH, Lin TL, Dunn P, et al. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia. 2004;18:466\u201375.","journal-title":"Leukemia"},{"key":"1022_CR24","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood.V91.8.2985.2985_2985_2990","volume":"91","author":"B Quesnel","year":"1998","unstructured":"Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F, et al. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood. 1998;91:2985\u201390.","journal-title":"Blood"},{"key":"1022_CR25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF02994004","volume":"73","author":"P Fenaux","year":"2001","unstructured":"Fenaux P. Chromosome and molecular abnormalities in myelodysplastic syndromes. Int J Hematol. 2001;73:429\u201337.","journal-title":"Int J Hematol"},{"key":"1022_CR26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.V95.4.1451.004k52_1451_1455","volume":"95","author":"N Tidow","year":"2000","unstructured":"Tidow N, Chen X, Muller C, Kawano S, Gombart AF, Fischel-Ghodsian N, et al. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood. 2000;95:1451\u20135.","journal-title":"Blood"},{"key":"1022_CR27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12185-010-0577-x","volume":"91","author":"C Oktenli","year":"2010","unstructured":"Oktenli C, Sayan O, Celik S, Erikci AA, Tunca Y, Terekeci HM, et al. High frequency of MEFV gene mutations in patients with myeloid neoplasm. Int J Hematol. 2010;91:758\u201361.","journal-title":"Int J Hematol"},{"key":"1022_CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1744-313X.2010.00938.x","volume":"37","author":"S Celik","year":"2010","unstructured":"Celik S, Erikci AA, Tunca Y, Sayan O, Terekeci HM, Umur EE, et al. The rate of MEFV gene mutations in hematolymphoid neoplasms. Int J Immunogenet. 2010;37:387\u201391.","journal-title":"Int J Immunogenet"},{"key":"1022_CR29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejmg.2005.05.010","volume":"48","author":"M Medlej-Hashim","year":"2004","unstructured":"Medlej-Hashim M, Serre JL, Corbani S, Saab O, Jalkh N, Delague V, et al. Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur J Med Genet. 2004;48:412.","journal-title":"Eur J Med Genet"},{"key":"1022_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","volume":"25","author":"RN Apte","year":"2006","unstructured":"Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor\u2013host interactions. Cancer Metastasis Rev. 2006;25:387\u2013408.","journal-title":"Cancer Metastasis Rev"},{"key":"1022_CR31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-065X.2008.00615.x","volume":"222","author":"RN Apte","year":"2008","unstructured":"Apte RN, Voronov E. Is interleukin-1 a good or bad \u2018guy\u2019 in tumor immunobiology and immunotherapy? Immunol Rev. 2008;222:222\u201341.","journal-title":"Immunol Rev"},{"key":"1022_CR32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.11199","volume":"92","author":"D Cilloni","year":"2007","unstructured":"Cilloni D, Martinelli G, Messa F, Baccarani M, Saglio G. Nuclear factor \u03baB as a target for new drug development in myeloid malignancies. Haematologica. 2007;92:1124\u20139.","journal-title":"Haematologica"},{"key":"1022_CR33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.exphem.2007.09.007","volume":"35","author":"DB Kerbauy","year":"2007","unstructured":"Kerbauy DB, Deeg HJ. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. Exp Hematol. 2007;35:1739\u201346.","journal-title":"Exp Hematol"},{"key":"1022_CR34","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2005-04-1424","volume":"106","author":"DM Kerbauy","year":"2005","unstructured":"Kerbauy DM, Lesnikov V, Abbasi N, Seal S, Scott B, Deeg HJ. NF-\u03baB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). Blood. 2005;106:3917\u201325.","journal-title":"Blood"},{"key":"1022_CR35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.cdd.4401874","volume":"13","author":"T Braun","year":"2006","unstructured":"Braun T, Carvalho G, Fabre C, Grosjean J, Fenaux P, Kroemer G. Targeting NF-\u03baB in hematologic malignancies. Cell Death Differ. 2006;13:748\u201358.","journal-title":"Cell Death Differ"},{"key":"1022_CR36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2004-04-1463","volume":"105","author":"C Frelin","year":"2005","unstructured":"Frelin C, Imbert V, Griessinger E, Peyron AC, Rochet N, Philip P, et al. Targeting NF-\u03baB activation via pharmacologic inhibition of IKK2 induced apoptosis of human acute myeloid leukaemia cells. Blood. 2005;105:804\u201311.","journal-title":"Blood"},{"key":"1022_CR37","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","volume":"98","author":"ML Guzman","year":"2001","unstructured":"Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, et al. Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukaemia cells. Blood. 2001;98:2301\u20137.","journal-title":"Blood"},{"key":"1022_CR38","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/sj.leu.2402641","volume":"16","author":"B Baumgartner","year":"2002","unstructured":"Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M, et al. Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts. Leukemia. 2002;16:2062\u201371.","journal-title":"Leukemia"},{"key":"1022_CR39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.humpath.2003.08.020","volume":"35","author":"CE Bueso-Ramos","year":"2003","unstructured":"Bueso-Ramos CE, Rocha FC, Shishodia S, Medeiros LJ, Kantarjian HM, Vadhan-Raj S, et al. Expression of constitutively active nuclear-kB RelA transcription factor in blasts of acute myeloid leukaemia. Hum Pathol. 2003;35:246\u201353.","journal-title":"Hum Pathol"},{"key":"1022_CR40","first-page":"1005","volume":"87","author":"C Sanz","year":"2002","unstructured":"Sanz C, Richard C, Prosper F, Fernandez-Luna JL. Nuclear factor \u03baB is activated in myelodysplastic bone marrow cells. Haematologica. 2002;87:1005\u20136.","journal-title":"Haematologica"},{"key":"1022_CR41","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood-2005-01-0428","volume":"107","author":"SK Biswas","year":"2006","unstructured":"Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3\/STAT1 activation). Blood. 2006;107:2112\u201322.","journal-title":"Blood"},{"key":"1022_CR42","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood.V92.9.3090","volume":"92","author":"Z Estrov","year":"1998","unstructured":"Estrov Z, Thall PF, Talpaz M, Estey EH, Kantarjian HM, Andreeff M, et al. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood. 1998;92:3090\u20137.","journal-title":"Blood"},{"key":"1022_CR43","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V94.8.2844.420k43_2844_2853","volume":"94","author":"Z Estrov","year":"1999","unstructured":"Estrov Z, Manna SK, Harris D, Van Q, Estey EH, Kantarjian HM, et al. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells. Blood. 1999;94:2844\u201353.","journal-title":"Blood"},{"key":"1022_CR44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/qjmed\/93.4.223","volume":"93","author":"G Grateau","year":"2000","unstructured":"Grateau G, Pecheux C, Cazeneuve C, Cattan D, Dervichian M, Goossens M, et al. Clinical versus genetic diagnosis of familial Mediterranean fever. Q J Med. 2000;93:223\u20139.","journal-title":"Q J Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1022-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1022-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1022-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T16:35:14Z","timestamp":1593707714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1022-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,18]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1022-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,18]]}}}